ICU Medical, Inc.
ICUI
株式のランク
#4021
ICU Medical, Inc., operating globally through its subsidiaries, is a medical... ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
株価
$161.56
最終同期: 2026-10-19
時価総額
$4.04B
変化（1日）
-0.87%
変化（1年）
37.69%
国
US
取引 ICU Medical, Inc. (ICUI)
カテゴリー
Healthcare
ICU Medical, Inc.（ICUI）のP/E比率
October 2026 時点のP/E比率 TTM 135.58
ICU Medical, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 135.58 です。2023 年末時点での P/E は -81.03 でした。
ICU Medical, Inc. の P/E 比率の履歴（2000 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 135.58 | -521.56% |
| 2024 | -32.16 | -60.32% |
| 2023 | -81.03 | 60.14% |
| 2022 | -50.60 | -203.68% |
| 2021 | 48.80 | -5.46% |
| 2020 | 51.62 | 35.11% |
| 2019 | 38.21 | -77.82% |
| 2018 | 172.27 | 179.12% |
| 2017 | 61.72 | 63.43% |
| 2016 | 37.76 | -4.95% |
| 2015 | 39.73 | -16.40% |
| 2014 | 47.53 | 105.27% |
| 2013 | 23.15 | 10.29% |
| 2012 | 20.99 | 50.62% |
| 2011 | 13.94 | -13.23% |
| 2010 | 16.06 | -20.47% |
| 2009 | 20.20 | 4.71% |
| 2008 | 19.29 | -13.44% |
| 2007 | 22.28 | -2.47% |
| 2006 | 22.85 | -14.46% |
| 2005 | 26.71 | -64.32% |
| 2004 | 74.86 | 253.96% |
| 2003 | 21.15 | -19.09% |
| 2002 | 26.14 | 5.58% |
| 2001 | 24.76 | 16.30% |
| 2000 | 21.29 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 47.48 | -64.98% |
US
|
|
| 27.43 | -79.77% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -58.03% |
US
|
|
| - | - |
CH
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。